NCT05853744

Brief Summary

The aim of the study was to evaluate the efficacy of lavender aromatherapy in reducing pre-operative anxiety in patients undergoing surgical procedures under spinal anesthesia. This was a prospective double blinded randomized controlled trial. After patient's approval, the anxiety level was assessed preoperativetively with Visual Analogue scale-anxiety and APAIS scale. To rule out any lavender sensitivity, all subjects were given a skin patch test. This was accomplished by applying a drop of lavender oil to the back of the hand and covering it with a Tegaderm dressing to prevent inhalation and spread of the oil. After randomisation and allocation, the investigators prooceeded with the intervention preoperatively. In the operating room, the acte under spinal anethesia was performed. Then we collect data postoperatively.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P25-P50 for phase_4 anxiety

Timeline
Completed

Started Aug 2023

Shorter than P25 for phase_4 anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 29, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 11, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

August 2, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2023

Completed
Last Updated

July 18, 2024

Status Verified

July 1, 2024

Enrollment Period

3 months

First QC Date

April 29, 2023

Last Update Submit

July 16, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Anxiety level

    Visual Analogue Scale (minimum value 0 means no anxiety and maximum value 10 means the highest anxiety level)

    before and 30 minutes after the intervention 2 hours befor surgery

Secondary Outcomes (3)

  • Pre-operative anxiety and information scale

    before and 30 minutes after the intervention 2 hours befor surgery

  • Anti-anxiety medications requirement

    Fifteen minutes before spinal anesthesia or during the act

  • Patient satisfaction

    2 hours after the end of the surgery

Study Arms (3)

Group C

EXPERIMENTAL

patients receiving aromatherapy using cotton balls impregnated with 3 drops of lavender essential oil inhaled from a distance of 10 cm during 20 minutes and pure oxygen administered through a face mask.

Drug: lavender essential oil inhaled using cotton balls

Group M

ACTIVE COMPARATOR

\- Group M: inhaled three drops of lavender oil through a facemask. These three drops were already diluted by five milliliters of distilled water and were sprayed in the area by a nebulizer. A cotton ball soaked with water was put 10 cm next to the patient.

Drug: lavender essential oil inhaled using face mask

Group P

PLACEBO COMPARATOR

Placebo group: inhaled five milliliters of distilled water in the same way as the patients in the experimental group and also cotton balls with 3 drops of water are placed near the patient.

Drug: Distilled water

Interventions

cotton balls impregnated with 3 drops of lavender essential oil inhaled from a distance of 10 cm during 20 minutes and pure oxygen administered through a face mask.

Also known as: Aromatherapy
Group C

These three drops were already diluted by five milliliters of distilled water and were sprayed in the area by a nebulizer throughout a face mask. A cotton ball soaked with water was put 10 cm next to the patient.

Also known as: Aromatherapy
Group M

inhaled five milliliters of distilled water in the same way as the patients in the experimental group and also cotton balls with 3 drops of water are placed near the patient.

Also known as: Placebo
Group P

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Surgery under spinal anesthesia: continuous or single shot;
  • Conscious patient cooperative able to communicate;
  • No preoperative cognitive disorder;
  • Patient consent;
  • American society of anesthesiologists' (ASA) physical status of I-III

You may not qualify if:

  • Pregnant or breastfeeding women;
  • Asthma;
  • Chronic obstructive pulmonary disease;
  • Allergic to essentials oils;
  • Anosmia;
  • History of chronic anxiety or depression;
  • Neuropsychiatric disorder;
  • Use of anti-anxiety medications or anti-depressants;
  • Drug addiction;
  • Emergency surgery required immediately or within 6 hours.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mongi Slim hospital

Tunis, 2085, Tunisia

Location

MeSH Terms

Conditions

Anxiety Disorders

Interventions

Aromatherapy

Condition Hierarchy (Ancestors)

Mental Disorders

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsPhytotherapySensory Art TherapiesPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Mhamed Sami MS Mebazaa, Pr

    Mongi Slim local

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Sequentially numbered and sealed opaque envelopes method was used to carry out the randomization and allocation. These were done by a different doctor from the one caring for the patient in the peri-operative period.
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 29, 2023

First Posted

May 11, 2023

Study Start

August 2, 2023

Primary Completion

October 31, 2023

Study Completion

December 30, 2023

Last Updated

July 18, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations